Dr Colin Wood

  • Clinical Lecturer in Surgery (Medicine)
  • Honorary Clinical Lecturer (School of Cancer Sciences)

email: Colin.Wood@glasgow.ac.uk

School of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow, G12 8QQ

Import to contacts

Publications

List by: Type | Date

Jump to: 2025 | 2024 | 2023 | 2022 | 2021
Number of items: 9.

2025

Haddad, T. S. et al. (2025) Tumor budding and poorly differentiated clusters as a biological continuum in colorectal cancer invasion and prognosis. Scientific Reports, 15(1), 16944. (doi: 10.1038/s41598-025-00866-x) (PMID:40374662) (PMCID:PMC12081641)

2024

Pennel, K. A.F. et al. (2024) JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors. Journal of Experimental and Clinical Cancer Research, 43, 64. (doi: 10.1186/s13046-024-02958-4)

2023

Haddad, T. S. et al. (2023) Pseudobudding: ruptured glands do not represent true tumor buds. Journal of Pathology, 261(1), pp. 19-27. (doi: 10.1002/path.6146) (PMID:37403270)

Sykes, R. A. et al. (2023) Vascular mechanisms of post-COVID-19 conditions: rho-kinase is a novel target for therapy. European Heart Journal: Cardiovascular Pharmacotherapy, 9(4), pp. 371-386. (doi: 10.1093/ehjcvp/pvad025) (PMID:37019821) (PMCID:PMC10236521)

Wood, C. S. et al. (2023) Spatially resolved transcriptomics deconvolutes prognostic histological subgroups in patients with colorectal cancer and synchronous liver metastases. Cancer Research, 83(8), pp. 1329-1344. (doi: 10.1158/0008-5472.CAN-22-2794) (PMID:37057593) (PMCID:PMC10102851)

2022

Fisher, N. C. et al. (2022) Biological misinterpretation of transcriptional signatures in tumour samples can unknowingly undermine mechanistic understanding and faithful alignment with preclinical data. Clinical Cancer Research, 28(18), pp. 4056-4069. (doi: 10.1158/1078-0432.CCR-22-1102) (PMID:35792866) (PMCID:PMC9475248)

Nassar, Ahmad, El Zanati, Hisham, Ng, Hwei J., Khan, Khurram S. ORCID logoORCID: https://orcid.org/0000-0002-8304-5970 and Wood, Colin (2022) Open conversion in laparoscopic cholecystectomy and bile duct exploration: subspecialisation safely reduces the conversion rates. Surgical Endoscopy, 36(1), pp. 550-558. (doi: 10.1007/s00464-021-08316-1) (PMID:33528666) (PMCID:PMC8741693)

2021

Nassar, Ahmad H.M., Ng, Auwei J., Ahmed, Zubir, Wysocki, Arkadiusz Peter, Wood, Colin and Abdellatif, Ayman (2021) Optimising the outcomes of index admission laparoscopic cholecystectomy and bile duct exploration for biliary emergencies: a service model. Surgical Endoscopy, 35(8), pp. 4192-4199. (doi: 10.1007/s00464-020-07900-1) (PMID:32860135)

Galbraith, Norman J. ORCID logoORCID: https://orcid.org/0000-0002-6354-6946, Wood, Colin and Steele, Colin W. ORCID logoORCID: https://orcid.org/0000-0001-8518-1223 (2021) Targeting metastatic colorectal cancer with immune oncological therapies. Cancers, 13(14), 3566. (doi: 10.3390/cancers13143566) (PMID:34298779) (PMCID:PMC8307556)

This list was generated on Mon Oct 20 22:59:22 2025 BST.
Jump to: Articles
Number of items: 9.

Articles

Haddad, T. S. et al. (2025) Tumor budding and poorly differentiated clusters as a biological continuum in colorectal cancer invasion and prognosis. Scientific Reports, 15(1), 16944. (doi: 10.1038/s41598-025-00866-x) (PMID:40374662) (PMCID:PMC12081641)

Pennel, K. A.F. et al. (2024) JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors. Journal of Experimental and Clinical Cancer Research, 43, 64. (doi: 10.1186/s13046-024-02958-4)

Haddad, T. S. et al. (2023) Pseudobudding: ruptured glands do not represent true tumor buds. Journal of Pathology, 261(1), pp. 19-27. (doi: 10.1002/path.6146) (PMID:37403270)

Sykes, R. A. et al. (2023) Vascular mechanisms of post-COVID-19 conditions: rho-kinase is a novel target for therapy. European Heart Journal: Cardiovascular Pharmacotherapy, 9(4), pp. 371-386. (doi: 10.1093/ehjcvp/pvad025) (PMID:37019821) (PMCID:PMC10236521)

Wood, C. S. et al. (2023) Spatially resolved transcriptomics deconvolutes prognostic histological subgroups in patients with colorectal cancer and synchronous liver metastases. Cancer Research, 83(8), pp. 1329-1344. (doi: 10.1158/0008-5472.CAN-22-2794) (PMID:37057593) (PMCID:PMC10102851)

Fisher, N. C. et al. (2022) Biological misinterpretation of transcriptional signatures in tumour samples can unknowingly undermine mechanistic understanding and faithful alignment with preclinical data. Clinical Cancer Research, 28(18), pp. 4056-4069. (doi: 10.1158/1078-0432.CCR-22-1102) (PMID:35792866) (PMCID:PMC9475248)

Nassar, Ahmad, El Zanati, Hisham, Ng, Hwei J., Khan, Khurram S. ORCID logoORCID: https://orcid.org/0000-0002-8304-5970 and Wood, Colin (2022) Open conversion in laparoscopic cholecystectomy and bile duct exploration: subspecialisation safely reduces the conversion rates. Surgical Endoscopy, 36(1), pp. 550-558. (doi: 10.1007/s00464-021-08316-1) (PMID:33528666) (PMCID:PMC8741693)

Nassar, Ahmad H.M., Ng, Auwei J., Ahmed, Zubir, Wysocki, Arkadiusz Peter, Wood, Colin and Abdellatif, Ayman (2021) Optimising the outcomes of index admission laparoscopic cholecystectomy and bile duct exploration for biliary emergencies: a service model. Surgical Endoscopy, 35(8), pp. 4192-4199. (doi: 10.1007/s00464-020-07900-1) (PMID:32860135)

Galbraith, Norman J. ORCID logoORCID: https://orcid.org/0000-0002-6354-6946, Wood, Colin and Steele, Colin W. ORCID logoORCID: https://orcid.org/0000-0001-8518-1223 (2021) Targeting metastatic colorectal cancer with immune oncological therapies. Cancers, 13(14), 3566. (doi: 10.3390/cancers13143566) (PMID:34298779) (PMCID:PMC8307556)

This list was generated on Mon Oct 20 22:59:22 2025 BST.